Factors predicting severe radiation pneumonitis in patients receiving definitive chemoradiation for lung cancer

Byhardt, 1995, The evolution of Radiation Therapy Oncology Group (RTOG) protocols for nonsmall cell lung cancer, Int J Radiat Oncol Biol Phys, 32, 1513, 10.1016/0360-3016(95)00084-C

Komaki, 1985, Characteristics of long-term survivors after treatment for inoperable carcinoma of the lung, Am J Clin Oncol, 8, 362, 10.1097/00000421-198510000-00005

ASCO Clinical practice guidelines for the treatment of unresectable non–small-cell lung cancer. J Clin Oncol 1997;15:2996–3018.

AJCC American Joint Committee on Cancer (AJCC) cancer staging manual. Philadelphia: Lippincott-Raven; 1997.

Bonomi, 1996, Escalating paclitaxel doses combined with carboplatin/etoposide and thoracic radiotherapy as preoperative or definitive treatment for stage III non–small cell lung cancer, Semin Oncol, 6, 102

Furuse, 1997, Phase II study of 3-hour infusion paclitaxel in patients with previously untreated stage III and IV non–small cell lung cancer, Oncol, 54, 298, 10.1159/000227707

Kleinbaum DG, Kupper LL, Muller KE. Applied regression analysis and other multivariable methods. Belmont: Duxbury Press; 1988. p. 512–516.

Byhardt, 1993, The influence of field size and other treatment factors on pulmonary toxicity following hyperfractionated irradiation for inoperable non–small cell lung cancer (NSCLC), Int J Radiat Oncol Biol Phys, 27, 537, 10.1016/0360-3016(93)90377-8

Gillam, 1964, Chronic bronchitis and radiotherapy of the lung, Lancet, 1, 1245, 10.1016/S0140-6736(64)91870-7

Hellman, 1964, Sequelae of radical radiotherapy of carcinoma of the lung, Radiology, 82, 1055, 10.1148/82.6.1055

Perez, 1980, A prospective study of various radiation doses and fractionation schedules in the treatment of inoperable non–oat-cell carcinoma of the lung, Cancer, 45, 2744, 10.1002/1097-0142(19800601)45:11<2744::AID-CNCR2820451108>3.0.CO;2-U

Sherman, 1982, The effect of dose rate and Adriamycin on the tolerance of thoracic radiation in mice, Int J Radiat Oncol Biol Phys, 8, 45, 10.1016/0360-3016(82)90383-2

vonderMasse H, Overgaard J, Vaeth M. Effect of cancer chemotherapeutic drugs on radiation-induced lung damage in mice. Radiother Oncol 1986;5:245–257.

Byhardt, 1998, Response, toxicity, failure patterns, and survival in five Radiation Therapy Oncology Group (RTOG) trials of sequential and/or concurrent chemotherapy and radiotherapy for locally advanced non–small cell carcinoma of the lung, Int J Radiat Oncol Biol Phys, 42, 469, 10.1016/S0360-3016(98)00251-X

Jeremic, 1996, Hyperfractionated radiation therapy with or without concurrent low-dose daily carboplatin/etoposide for stage III non–small cell lung cancer, J Clin Oncol, 14, 1065, 10.1200/JCO.1996.14.4.1065

Schaake-Konig, 1992, Effects of concomitant cisplatin and radiotherapy on inoperable non–small cell lung cancer, N Engl J Med, 326, 524, 10.1056/NEJM199202203260805

Dillman, 1990, A randomized trial of induction chemotherapy plus high-dose radiation vs. radiation alone in stage III non–small cell lung cancer, N Engl J Med, 323, 940, 10.1056/NEJM199010043231403

Roberts, 1993, Radiation pneumonitis, Ann Intern Med, 118, 696, 10.7326/0003-4819-118-9-199305010-00006

Morgan, 1995, Radiation and the lung, Int J Radiat Oncol Biol Phys, 31, 361, 10.1016/0360-3016(94)00477-3

Choi, 1985, Physiologic changes in pulmonary function after thoracic radiotherapy for lung cancer and the role of regional pulmonary function studies in predicting post-radiotherapy pulmonary function, Cancer Treatment Symposia, 2, 119

Roach, 1995, Radiation pneumonitis following combined modality therapy for lung cancer, J Clin Oncol, 13, 2606, 10.1200/JCO.1995.13.10.2606

Armstrong, 1995, Strategy for dose escalation using 3-dimensional conformal radiation therapy for lung cancer, Ann Oncol, 6, 693, 10.1093/oxfordjournals.annonc.a059286

Graham, 1996, 3-D conformal radiotherapy for lung cancer, Front Radiat Ther Oncol, 29, 188, 10.1159/000424718

Kwa, 1998, Radiation pneumonitis as a function of mean lung dose, Int J Radiat Oncol Biol Phys, 42, 1, 10.1016/S0360-3016(98)00196-5

Martel, 1994, DVH and 3-D treatment planning evaluation of patients with pneumonitits, Int J Radiat Oncol Biol Phys, 28, 575, 10.1016/0360-3016(94)90181-3

Robertson, 1997, Dose escalation for non–small cell lung cancer using conformal radiation therapy, Int J Radiat Oncol Biol Phys, 37, 1079, 10.1016/S0360-3016(96)00593-7